Oncology & Hematolgy Trials: A Conversation with Adam Callahan (full interview)

Adam Callahan provides an overview of Caidya’s approach to hematology and oncology clinical development. He describes a global team of dedicated professionals who combine deep therapeutic knowledge with an understanding of regulatory complexity and clinical operations. The discussion highlights how Caidya’s medical, scientific, and operational specialists can engage with sponsors at key points throughout drug development. This support can begin with preclinical and upstream planning, continue through clinical development, and extend into commercial launch strategy. Throughout the development process, the team remains focused on the needs of sponsors, clinicians, and patients.